JP2020526530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526530A5 JP2020526530A5 JP2020500810A JP2020500810A JP2020526530A5 JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5 JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- lipid
- peptide antigens
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762530498P | 2017-07-10 | 2017-07-10 | |
| US62/530,498 | 2017-07-10 | ||
| PCT/CA2017/051336 WO2019010560A1 (en) | 2017-07-10 | 2017-11-09 | PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION USING LIPID VESICLE PARTICLES OF A DEFINED SIZE, AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020526530A JP2020526530A (ja) | 2020-08-31 |
| JP2020526530A5 true JP2020526530A5 (enExample) | 2020-12-10 |
| JP7409594B2 JP7409594B2 (ja) | 2024-01-09 |
Family
ID=65000992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500810A Active JP7409594B2 (ja) | 2017-07-10 | 2017-11-09 | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200230057A1 (enExample) |
| EP (1) | EP3651733A4 (enExample) |
| JP (1) | JP7409594B2 (enExample) |
| CN (1) | CN111093623A (enExample) |
| AU (1) | AU2017423053A1 (enExample) |
| CA (1) | CA3069019A1 (enExample) |
| WO (1) | WO2019010560A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3768242A4 (en) * | 2018-03-20 | 2021-12-08 | ImmunoVaccine Technologies Inc. | METHODS AND COMPOSITIONS FOR THE TARGETED DELIVERY OF ACTIVE SUBSTANCES AND IMMUNMODULATORY AGENTS TO LYMPH NODES |
| CN113329761A (zh) | 2018-09-04 | 2021-08-31 | 特雷斯生物有限公司 | 肽疫苗 |
| AU2020221280B2 (en) | 2019-02-15 | 2026-04-23 | Cleveland Clinic Foundation | Vaccine adjuvants and formulations |
| CA3136066A1 (en) * | 2019-04-05 | 2020-10-08 | Sumitomo Dainippon Pharma Co., Ltd. | Water soluble adjuvant and composition containing same |
| BR112021023726A2 (pt) | 2019-05-25 | 2022-02-15 | Infectious Disease Res Inst | Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante |
| US20230348935A1 (en) * | 2020-09-24 | 2023-11-02 | Nant Holdings Ip, Llc | Vaccine compositions for mucosal immune response |
| CA3197163A1 (en) * | 2020-09-28 | 2022-03-31 | Immunovaccine Technologies Inc. | Lipid compositions comprising polynucleotide antigens |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906110A (en) * | 1959-09-29 | Silencing attachment for seamless | ||
| JP4705591B2 (ja) * | 2004-01-07 | 2011-06-22 | バイオメディカル リサーチ モデルズ， インコーポレイテッド | 抗原または免疫原に対する免疫応答を仕立てる方法。 |
| CA2723918C (en) * | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| JP5429710B2 (ja) * | 2009-03-30 | 2014-02-26 | 独立行政法人放射線医学総合研究所 | 治療薬剤の標的部位への集積及び放出を追跡可能な治療薬剤含有リポソームおよびその製造方法 |
| KR101102834B1 (ko) * | 2010-02-24 | 2012-01-05 | 충남대학교산학협력단 | 신규한 리포좀 제조 방법 및 장치 |
| CU20100144A7 (es) * | 2010-07-06 | 2012-06-21 | Centro Inmunologia Molecular | Composiciones vacunales a base de sticholisina encapsulada en liposomas |
| JP2014519496A (ja) * | 2011-05-11 | 2014-08-14 | ナノヴァレント ファーマシューティカルズ，インコーポレイテッド | Ａｌｃａｍ細胞表面受容体を標的とする細胞毒性重合リポソームナノ粒子による増強された骨肉腫の増殖抑制 |
| IN2014CN02581A (enExample) * | 2011-10-06 | 2015-08-07 | Immunovaccine Technologies Inc | |
| PT2768484T (pt) * | 2011-10-21 | 2019-10-28 | Jazz Pharmaceuticals Res Llc | Lipossomas liofilizados |
| CA2853689C (en) * | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| BR112015000174A2 (pt) * | 2012-07-05 | 2017-06-27 | Taiwan Liposome Co Ltd | método para o tratamento da artrite |
| US9693958B2 (en) * | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
| JP7028774B2 (ja) * | 2015-08-19 | 2022-03-02 | シャンハイ ギンポサム ファーマテック カンパニー リミテッド | ギンセノシドを膜材料として有するリポソームならびにその調製および使用 |
| US11160861B2 (en) * | 2015-11-18 | 2021-11-02 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant |
| WO2017097196A1 (zh) * | 2015-12-08 | 2017-06-15 | 正大天晴药业集团股份有限公司 | 脂质体的制备方法 |
-
2017
- 2017-11-09 US US16/629,780 patent/US20200230057A1/en not_active Abandoned
- 2017-11-09 JP JP2020500810A patent/JP7409594B2/ja active Active
- 2017-11-09 CN CN201780094129.5A patent/CN111093623A/zh active Pending
- 2017-11-09 WO PCT/CA2017/051336 patent/WO2019010560A1/en not_active Ceased
- 2017-11-09 CA CA3069019A patent/CA3069019A1/en active Pending
- 2017-11-09 EP EP17917340.6A patent/EP3651733A4/en not_active Withdrawn
- 2017-11-09 AU AU2017423053A patent/AU2017423053A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7604519B2 (ja) | Ｒｎａコンストラクトおよびその使用 | |
| Riccardi et al. | Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field | |
| Nordly et al. | Immunity by formulation design: induction of high CD8+ T-cell responses by poly (I: C) incorporated into the CAF01 adjuvant via a double emulsion method | |
| US8926994B2 (en) | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity | |
| Li et al. | Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy | |
| US11060096B2 (en) | RNA-based compositions and adjuvants for prophylactic and therapeutic treatment | |
| JP2025107179A (ja) | 治療に好適なｒｎａ製剤 | |
| KR101308591B1 (ko) | 양이온성 지질을 포함하는 음이온성 약물 전달체 및 그 제조방법 | |
| CN103372217B (zh) | 聚合物纳米载体制剂及其制备方法和应用 | |
| JP2014522842A5 (enExample) | ||
| Avila et al. | Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules | |
| JP2018065821A5 (enExample) | ||
| WO2023000403A1 (zh) | 一种新型冠状病毒亚蛋白纳米疫苗及其制备方法和应用 | |
| CN105980447A (zh) | 二氧化硅囊泡的合成方法及其用途 | |
| JP7409594B2 (ja) | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 | |
| US20240398918A1 (en) | Design of immunostimulatory protein-core spherical nucleic acids | |
| WO2016062227A1 (zh) | 聚乙二醇化磷脂为载体的胶束多肽疫苗 | |
| Mody et al. | Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions | |
| Marin et al. | Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine | |
| WO2026007297A1 (zh) | 一种高效跨粘膜障碍并诱导粘膜免疫强化的多功能仿生递送平台的制备方法及应用 | |
| Palumbo et al. | Bacterial invasin: structure, function, and implication for targeted oral gene delivery | |
| CN102369242B (zh) | 包含疏水化聚氨基酸的聚离子复合物及其用途 | |
| JPWO2022244825A5 (enExample) | ||
| JP2003526692A (ja) | ポリヌクレオチド組成物 | |
| Gupta et al. | Immunomodulatory potential of nanomaterials: Interaction with the immune system |